No Benefit Found for COVID-19 Convalescent Plasma in High-Risk Outpatients
Disease progression was not reduced with convalescent plasma for outpatients aged 50 years or older with one or more risk factors
Pain, Fatigue, Depression, Anxiety Prevalent After MS Diagnosis
Most patients had co-occurring symptoms: 21.3, 19.1, and 17.4 percent had two, three, and four symptoms, respectively
Poverty Tied to Worse Functional Status in Rheumatoid Arthritis
Patients with lower socioeconomic status also have increased probability of functional decline in longitudinal analyses
More Than 10 Percent of Adults Missed Health Care in Spring 2021
In addition, 9.2 percent of parents report delaying or forgoing care for their children for fear of exposure to the coronavirus
Salmonella Illness in 17 States Tied to Salami, Prosciutto
Twelve people have been hospitalized; no deaths have been reported
Stop Using Ivermectin Veterinary Drug to Treat COVID-19, FDA Urges
No form of ivermectin has been approved to treat or prevent COVID-19, the agency emphasized
Pfizer-BioNTech COVID-19 Vaccine Receives Full FDA Approval
Prescribing information includes warning about risks for myocarditis and pericarditis, particularly in men younger than 40 years
Higher Flavonoid Intake May Lower Systolic Blood Pressure
Higher consumption of berries, red wine linked to lower SBP; association partly explained by microbial factors
No Permanent Lung Damage Observed After COVID-19 Recovery
No difference seen between lung parenchyma of COVID-19 survivors and controls in specimens from unrelated elective lung resections
Teens, Young Men Have Higher SARS-CoV-2 Infection Rates
Standardized infection ratios were lowest in children and in adults aged 70 years or older compared with overall population
